EGFR and neoplasm: PD-L1 overexpression is promoted by oncogenic and constitutive activation signals, including EGFR, Kirsten rat sarcoma virus oncogene homolog (KRAS), and protein kinase B (AKT), which are mechanisms of cell-intrinsic tumor resistance (21, 43, 44).